Merck KGaA has entered into an agreement with Oriola Oy of Finland, forthe distribution of its pharmaceutical products in that country, effective January 1, 2002. At present, annual sales of Merck Oy, the German firm's subsidiary in Finland, are put at 10.2 million euros ($9.3 million).
Oriola is a health care wholesale and distribution company, including pharmaceutical products, and has annual invoiced sales of about 600 million euros. Its share of pharmaceutical distribution in Finland is around one-third.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze